Back to News
Market Impact: 0.25

PFE Quantitative Stock Analysis

PFENDAQ
Company FundamentalsCapital Returns (Dividends / Buybacks)Healthcare & BiotechAnalyst InsightsValuation
PFE Quantitative Stock Analysis

Pfizer Inc. (PFE) received a 70% rating from Validea's Meb Faber Shareholder Yield Investor model, which identifies companies returning cash to shareholders via dividends, buybacks, and debt paydown. While this large-cap growth stock passed criteria such as Net Payout Yield, Valuation, and Relative Strength, it notably failed on 'Quality and Debt' and the specific 'Shareholder Yield' metric, indicating a nuanced fundamental profile despite the model's overall interest.

Analysis

According to Validea's fundamental report, Pfizer Inc. (PFE) presents a mixed profile based on the Meb Faber Shareholder Yield Investor model. The company scored a 70% rating, which is below the 80% threshold that typically indicates model interest, despite being the highest score PFE received among 22 strategies. The analysis reveals specific strengths, with PFE passing tests for Net Payout Yield, Valuation, and Relative Strength, suggesting favorable cash returns to shareholders, an attractive valuation, and positive market momentum. However, these strengths are counterbalanced by significant weaknesses, as the company failed on two critical metrics: 'Quality and Debt' and the composite 'Shareholder Yield' test itself. The failure on the quality and debt screen indicates potential balance sheet risks, while the failure on the overall shareholder yield metric, despite passing the net payout yield component, points to a nuanced or potentially less effective capital return strategy when fully evaluated by the model's criteria.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

NDAQ0.00
PFE0.10

Key Decisions for Investors

  • Investors should scrutinize Pfizer's balance sheet, particularly its debt levels and structure, given the explicit 'FAIL' rating on the 'Quality and Debt' criterion.
  • The attractive valuation and positive relative strength may appeal to value-oriented investors, but this should be weighed against the fundamental risks highlighted by the model.
  • Given the conflicting signals between passing 'Net Payout Yield' and failing 'Shareholder Yield', investors focused on capital returns should seek to understand the specific composition of PFE's dividend, buyback, and debt paydown activities to resolve the discrepancy.